Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?
Plus
12
Ṁ3172026
73%
chance
1D
1W
1M
ALL
Resolves to YES if a statistically significant difference in lifespan between any treatment group and every control group is shown in any scientific journal article published by the Dog Aging Project team as a result of their ongoing non-clinical trial(s) in dogs.
Resolves to NO if this does not happen by 31 DEC 2026.
Link to DAP: https://dogagingproject.org/
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Sort by:
doesnt work + false negative + delays / lose funding make 77 seem high imo. spent 30 seconds thinking about it though so idk
Related questions
Related questions
Does rapamyacin significantly increase the lifespan of dogs?
71% chance
What percent of those taking rapamycin to slow aging will comment a positive or neutral review?
56% chance
By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?
What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
Will any molecule be shown to extend longevity in the ITP program in 2024?
48% chance
Will the Robust Mouse Rejuvenation Study by the LEVF succeed in increasing mouse lifespan 12 months?
36% chance
Will the Rapamycin - Effects on Alzheimer's and Cognitive Health (REACH) trial show that Rapamycin improves Alzheimer's
26% chance
Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?
43% chance
Will Aubrey de Grey's 2022 Robust Mouse Rejuvenation Project "succeed" in its aims of finding an intervention that increases both mean and maximum lifespan of mice by at least 12 months?
34% chance
Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)
32% chance